Efficacy of cefepime in a Staphylococcus aureus endocarditis rat model

Area of Science:

• Infectious Diseases
• Pharmacology
• Bacteriology

Background:

• Staphylococcus aureus is a common cause of infective endocarditis.
• Penicillin-resistant strains pose a significant treatment challenge.
• Evaluating novel antibiotics is crucial for combating resistant bacterial infections.

Purpose of the Study:

• To assess the efficacy of cefepime against Staphylococcus aureus endocarditis in rats.
• To compare cefepime's effectiveness with other antibiotics, including cefpirome, ceftazidime, vancomycin, imipenem-cilastatin, and penicillin G.
• To evaluate the pharmacokinetic properties of cephalosporins in the study model.

Main Methods:

• A rat model of endocarditis was established using a penicillin-resistant strain of Staphylococcus aureus.
• Animals were treated with various antibiotics, including cefepime, and compared to untreated controls.
• Bacterial counts in cardiac vegetations and serum antimicrobial concentrations were determined.

Main Results:

• Cefepime, cefpirome, ceftazidime, imipenem-cilastatin, and vancomycin significantly reduced bacterial counts in cardiac vegetations.
• Penicillin G showed no efficacy in reducing bacterial load.
• Pharmacokinetic parameters for the cephalosporins were comparable among the tested agents.

Conclusions:

• Cefepime demonstrates significant efficacy in a rat model of Staphylococcus aureus endocarditis.
• The new cephalosporin, cefepime, is a potential therapeutic option for staphylococcal endocarditis.
• Further clinical investigation into cefepime for staphylococcal endocarditis is warranted.